Shopping Cart
- Remove All
Your shopping cart is currently empty
Naveglitazar (LY 519818, LY 9818) is a peroxisome proliferator-activated receptor (PPAR) modulator, which has entered phase II clinical trials for the treatment of type 2 diabetes.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $3,150 | 6-8 weeks | |
| 50 mg | $4,160 | 6-8 weeks | |
| 100 mg | $5,250 | 6-8 weeks |
| Description | Naveglitazar (LY 519818, LY 9818) is a peroxisome proliferator-activated receptor (PPAR) modulator, which has entered phase II clinical trials for the treatment of type 2 diabetes. |
| Synonyms | LY-9818, LY9818, LY-519818, LY519818, LY 9818, LY 519818 |
| Molecular Weight | 422.47 |
| Formula | C25H26O6 |
| Cas No. | 476436-68-7 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.